Story perspectives
Breakthrough Nanostructure Triples CRISPR Effectiveness for Gene Therapy
9/26/2025
1 of 1
Story summary
- Northwestern University researchers developed a nanostructure that enhances CRISPR entry into cells, tripling its effectiveness in treating genetic diseases.
- Lipid nanoparticle spherical nucleic acids (LNP-SNAs) improve CRISPR delivery, reducing toxicity and boosting gene-editing efficiency by over 60%.
- Clinical trials are underway for CRISPR-based therapies, with promising results in treating blood diseases and type 1 diabetes.
